FactEvidence 1
producesneurostimulation products
No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-08 23:15
View evidence
- MediaGDELT Global Knowledge Graph2026-10-08 23:15View source
Company
Nexalin Technology, Inc.
Structure of Nexalin Technology, Inc.
Nexalin Technology, Inc.
Company
0 connections
Relationship began
Nexalin Technology, Inc.Company · 0 connections
Layer 1No public connections yet.
Relations
Arrows show the direction of the relationship. Filter to focus on a business area.
- Fact90%
View evidence
- CompanyGlobeNewswire public company news2026-10-08 20:30
Nexalin products are developed to provide relief to those afflicted with mental health issues using frequency based bioelectronic medical technology.
View source
- Product · neurostimulation productsEvidence 1Fact55%
View evidence
- MediaGDELT Global Knowledge Graph2026-10-08 23:15View source
Showing 1 to 2 of 2
Claims
Read the assertion alongside its sources. Expand a row to inspect the evidence.
FactEvidence 2
minimum stockholders equity requirement$2.5 million
must demonstrate compliance with the minimum $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) on or before January 4, 2027.
GDELT Global Knowledge Graph · GlobeNewswire public company news · 2026-10-08 23:15
View evidence
- MediaGDELT Global Knowledge Graph2026-10-08 23:15View source
- CompanyGlobeNewswire public company news2026-10-08 20:30
must demonstrate compliance with the minimum $2.5 million stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) on or before January 4, 2027.
View source
FactEvidence 2
deadline to demonstrate compliance with minimum stockholders equity requirementJanuary 4, 2027
No public evidence summary is available.
GDELT Global Knowledge Graph · 2026-10-08 23:15
View evidence
- MediaGDELT Global Knowledge Graph2026-10-08 23:15View source
- MediaGDELT Global Knowledge Graph2026-10-08 21:00View source
FactEvidence 1
Nexalin products are developed to provide relief to those afflicted with mental health issues using frequency based bioelectronic medical technology.
GlobeNewswire public company news · 2026-10-08 20:30
View evidence
- CompanyGlobeNewswire public company news2026-10-08 20:30
Nexalin products are developed to provide relief to those afflicted with mental health issues using frequency based bioelectronic medical technology.
View source
Showing 1 to 4 of 4
Market and valuation
Valuation data is available on Pro and Research.
Included in ProNot available: Company signals · Financials · Filings · Guidance